Signia Therapeutics announces it has been selected to present its strategy based on clinical gene expression infection signatures to t ...
Signia Therapeutics announces it has been invited to present company and update of development at the upcoming 6th ISIRV-AVG “Advan ...
Signia Therapeutics announces an agreement with SANOFI to evaluate potential pipeline candidates LYON, FRANCE (November 1, 2018) ...
Signia Therapeutics announces the nomination of Dr. Philippe Personne as CEO, effective as of 1st of October. Dr. Personne graduate ...
Signia Therapeutics is pleased to announce that it will participate at the Bio Europe partnering conference in Copenhagen on November ...
Signia Therapeutics is pleased to announce that it will have several activities during the BIO 2018 that will be held in Boston ...
Do not hesitate to contact us!
Signia therapeutics.com - Copyright 2018. All right reserved.
